Schouten HC - Search Results

1

Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia.

Koopmans SM, Schouten HC, van Marion AM. Koopmans SM, et al. Among authors: schouten hc. Pathobiology. 2014;81(2):60-8. doi: 10.1159/000356187. Epub 2013 Nov 20. Pathobiology. 2014. PMID: 24280934

2

The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation.

Schouten HC, van Putten WL, Hagemeijer A, Blijham GH, Sonneveld P, Willemze R, Slater R, van de Lely J, Verdonck LF, Löwenberg B. Schouten HC, et al. Bone Marrow Transplant. 1991 Nov;8(5):377-81. Bone Marrow Transplant. 1991. PMID: 1768973 Clinical Trial.

3

Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation.

Schouten HC, Hopman AH, Haesevoets AM, Arends JW. Schouten HC, et al. Br J Haematol. 1995 Sep;91(1):162-6. doi: 10.1111/j.1365-2141.1995.tb05262.x. Br J Haematol. 1995. PMID: 7577625

4

Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma.

Gisbertz IA, Schouten HC, Bot FJ, Arends JW. Gisbertz IA, et al. Among authors: schouten hc. Histopathology. 1997 Feb;30(2):152-9. doi: 10.1046/j.1365-2559.1997.d01-573.x. Histopathology. 1997. PMID: 9067740

5

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes.

Lalisang RI, Hupperets PS, ten Haaft MA, Jansen RL, Schouten HC. Lalisang RI, et al. Among authors: schouten hc. Bone Marrow Transplant. 1998 Feb;21(3):243-7. doi: 10.1038/sj.bmt.1701071. Bone Marrow Transplant. 1998. PMID: 9489646 Clinical Trial.

6

Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma.

Gisbertz IA, Schouten HC, Bot FJ, Arends JW. Gisbertz IA, et al. Among authors: schouten hc. Cancer. 1998 Jul 1;83(1):158-65. doi: 10.1002/(sici)1097-0142(19980701)83:1<158::aid-cncr21>3.0.co;2-v. Cancer. 1998. PMID: 9655306

7

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

Jansen RL, Joosten-Achjanie SR, Volovics A, Arends JW, Hupperets PS, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: schouten hc. Anticancer Res. 1998 Nov-Dec;18(6A):4455-62. Anticancer Res. 1998. PMID: 9891509

8

Diagnosis, staging and prognostic factors.

Schouten HC. Schouten HC. Ann Oncol. 2007 Jan;18 Suppl 1:i22-i28. doi: 10.1093/annonc/mdl446. Ann Oncol. 2007. PMID: 17311817 Review. No abstract available.

9

General principles of treatment.

Schouten HC. Schouten HC. Ann Oncol. 2007 Jan;18 Suppl 1:i29-i32. doi: 10.1093/annonc/mdl447. Ann Oncol. 2007. PMID: 17311818 Review. No abstract available.

10

Response evaluation and long-term follow-up.

Schouten HC. Schouten HC. Ann Oncol. 2007 Jan;18 Suppl 1:i33-i36. doi: 10.1093/annonc/mdl448. Ann Oncol. 2007. PMID: 17311820 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results